Induction and attenuation of neuronal apoptosis by proteasome inhibitors in murine cortical cell cultures

Journal of Neurochemistry

Volumn 95, Issue 3, 2005, Pages 684-694

  Suh, Jaehong ^a   Lee, Young Ae ^a,b   Gwag, Byoung Joo ^a,b  

^a Ajou University School of Medicine   (South Korea)

^b Neurotech Pharmaceuticals Co   (South Korea)

Author keywords

Inhibitor of apoptosis protein; MG132; Mitochondria; Neuronal apoptosis; Proteasome

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CASPASE 3; CASPASE 9; CYTOCHROME C; LACTACYSTIN; PROTEASOME; PROTEASOME INHIBITOR; TAU PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN MITOCHONDRION; BRAIN NERVE CELL; CELL PROTECTION; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME INHIBITION; FETUS; IMMUNOCYTOCHEMISTRY; MOUSE; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CASPASE 3; CASPASES; CELLS, CULTURED; CEREBRAL CORTEX; CYSTEINE PROTEINASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; INHIBITOR OF APOPTOSIS PROTEINS; LEUPEPTINS; MICE; MITOCHONDRIA; NEURONS; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITIN;

ANIMALIA; INTRACISTERNAL A-PARTICLES; MURINAE;

EID: 27644484454     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03393.x     Document Type: Article

References (40)

1. Bence N. F., Sampat R. M. and Kopito R. R. (2001) Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292, 1552-1555,
2. Bobba A., Canu N., Atlante A., Petragallo V., Calissano P. and Marra E. (2002) Proteasome inhibitors prevent cytochrome c release during apoptosis but not in excitotoxic death of cerebellar granule neurons. FEBS Lett. 515, 8-12.
3. Bochtler M., Ditzel L., Groll M., Hartmann C. and Huber R. (1999) The proteasome. Annu. Rev. Biophys. Biomol. Struct. 28, 295-317.
4. Canu N., Barbato C., Ciotti M. T., Serafino A., Dus L. and Calissano P. (2000) Proteasome involvement and accumulation of ubiquitinated proteins in cerebellar granule neurons undergoing apoptosis, J. Neurosci. 20, 589-599.
5. Chung C. W., Song Y. H., Kim I. K. et al. (2001a) Proapoptotic effects of tau cleavage product generated by caspase-3, Neurobiol. Dis. 8, 162-172.
6. Chung K. K., Dawson V. L. and Dawson T. M. (2001b) The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders. Trends Neurosci. 24, S7-S14.
7. Ciechanover A. (1998) The ubiquitin-proteasome pathway: on protein death and cell life. EMBO J. 17, 7151-7160.
8. Desagher S. and Martinou J. C. (2000) Mitochondria as the central control point of apoptosis. Trends Cell Biol. 10, 369-377.
9. Ditzel M. and Meier P. (2002) IAP degradation: decisive blow or altruistic sacrifice? Trends Cell Biol. 12, 449-452.
10. Favit A., Grimaldi M. and Alkon D. L. (2000) Prevention of beta-amyloid neurotoxicity by blockade of the ubiquitin-proteasome proteolytic pathway. J. Neurochem. 75, 1258-1263.
11. Grimm L. M., Goldberg A. L., Poirier G. G., Schwartz L. M. and Osborne B. A. (1996) Proteasomes play an essential role in thymocyte apoptosis. EMBO J. 15, 3835-3844.
12. Gwag B. J., Koh J. Y., DeMaro J. A., Ying H. S., Jacquin M. and Choi D. W. (1997) Slowly triggered excitotoxicity occurs by necrosis in cortical cultures. Neuroscience 77, 393-401.
13. Jana N. R., Zemskov E. A., Wang G. and Nukina N. (2001) Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release. Hum. Mol. Genet. 10, 1049-1059.
14. Keck S., Nitsch R., Grune T. and Ullrich O. (2003) Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease. J. Neurochem. 85, 115-122.
15. Keller J. N., Hanni K. B. and Markesbery W. R. (2000) Impaired proteasome function in Alzheimer's disease. J. Neurochem. 75, 436-439.
16. Kim S. H., Won S. J., Sohn S., Kwon H. J., Lee J. Y., Park J. H. and Gwag B. J. (2002) Brain-derived neurotrophic factor can act as a pronecrotic factor through transcriptional and translational activation of NADPH oxidase. J. Cell Biol. 159, 821-831.
17. Ko H. W., Han K. S., Kim E. Y., Ryu B. R., Yoon W. J., Jung Y. K., Kim S. U. and Gwag B. J. (2000) Synergetic activation of p38 mitogen-activated protein kinase and caspase-3-like proteases for execution of calyculin A-induced apoptosis but not N-methyl-D-aspartate-induced necrosis in mouse cortical neurons. J. Neurochem. 74, 2455-2461.
18. Koh J. Y., Gwag B. J., Lobner D. and Choi D. W. (1995) Potentiated necrosis of cultured cortical neurons by neurotrophins. Science 268, 573-575.
19. Leroy E., Boyer R., Auburger G. et al. (1998) The ubiquitin pathway in Parkinson's disease. Nature 395, 451-452.
20. Lin K. I., Baraban J. M. and Ratan R. R. (1998) Inhibition versus induction of apoptosis by proteasome inhibitors depends on concentration. Cell Death. Differ. 5, 577-583.
21. Lindsten K., Menendez-Benito V., Masucci M. G. and Dantuma N. P. (2003) A transgenic mouse model of the ubiquitin/proteasome system. Nat. Biotechnol. 21, 897-902.
22. Lopez S. M., Morelli L., Castano E. M., Soto E. F. and Pasquini J. M. (2000) Defective ubiquitination of cerebral proteins in Alzheimer's disease. J. Neurosci. Res. 62, 302-310.
23. McNaught K. S., Belizaire R., Isacson O., Jenner P. and Olanow C. W. (2003) Altered proteasomal function in sporadic Parkinson's disease. Exp. Neurol. 179, 38-46.
24. Naujokat C. and Hoffmann S. (2002) Role and function of the 26S proteasome in proliferation and apoptosis. Lab. Invest. 82, 965-980.
25. Noh J. S. and Gwag B. J. (1997) Attenuation of oxidative neuronal necrosis by a dopamine D1 agonist in mouse cortical cell cultures. Exp. Neurol. 146, 604-608.
26. Pasquini L. A., Besio M. M., Adamo A. M., Pasquini J. M. and Soto E. F. (2000) Lactacystin, a specific inhibitor of the proteasome, induces apoptosis and activates caspase-3 in cultured cerebellar granule cells. J. Neurosci. Res. 59, 601-611.
27. Piccioli P., Porcile C., Stanzione S., Bisaglia M., Bajetto A., Bonavia R., Florio T. and Schettini G. (2001) Inhibition of nuclear factor-kappaB activation induces apoptosis in cerebellar granule cells. J. Neurosci. Res. 66, 1064-1073.
28. Pitzer F., Dantes A., Fuchs T., Baumeister W. and Amsterdam A. (1996) Removal of proteasomes from the nucleus and their accumulation in apoptotic blebs during programmed cell death. FEBS Lett. 394, 47-50.
29. Qiu J. H., Asai A., Chi S., Saito N., Hamada H. and Kirino T. (2000) Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured cortical neurons. J. Neurosci. 20, 259-265.
30. Sadoul R., Fernandez P. A., Quiquerez A. L., Martinou I., Maki M., Schroter M., Becherer J. D., Irmler M., Tschopp J. and Martinou J. C. (1996) Involvement of the proteasome in the programmed cell death of NGF-deprived sympathetic neurons. EMBO J. 15, 3845-3852.
31. Stefanelli C., Bonavita F., Stanic I., Pignatti C., Farraggia G., Masotti L., Guarnieri C. and Caldarera C. M. (1998) Inhibition of etoposide-induced apoptosis with peptide aldehyde inhibitors of proteasome. Biochem. J. 332, 661-665.
32. Takeda A., Mallory M., Sundsmo M., Honer W., Hansen L. and Masliah E. (1998) Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders. Am. J. Pathol. 152, 367-372.
33. Tonomura N., McLaughlin K., Grimm L., Goldsby R. A. and Osborne B. A. (2003) Glucocorticoid-induced apoptosis of thymocytes: requirement of proteasome-dependent mitochondrial activity. J. Immunol. 170, 2469-2478.
34. Tsuruta F., Sunayama J., Mori Y., Hattori S., Shimizu S., Tsujimoto Y., Yoshioka K., Masuyama N. and Gotoh Y. (2004) JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins. EMBO J. 23, 1889-1899.
35. Won J., Kim D. Y., La M., Kim D., Meadows G. G. and Joe C. O. (2003) Cleavage of 14-3-3 protein by caspase-3 facilitates bad interaction with Bcl-X(L) during apoptosis. J. Biol. Chem. 278, 19 347-19 351.
36. Won S. J., Park E. C., Ryu B. R., Ko H. W., Sohn S., Kwon H. J. and Gwag B. J. (2000) NT-4/5 exacerbates free radical-induced neuronal necrosis in vitro and in vivo. Neurobiol. Dis. 7, 251-259.
37. Yang Y., Fang S., Jensen J. P., Weissman A. M. and Ashwell J. D. (2000) Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science 288, 874-877.
38. 2+ deficiency. J. Neurochem. 85, 525-533.
39. Yu L. Y., Korhonen L., Martinez R., Jokitalo E., Chen Y., Arumae U. and Lindholm D. (2003) Regulation of sympathetic neuron and neuroblastoma cell death by XIAP and its association with proteasomes in neural cells. Mol. Cell. Neurosci. 22, 308-318.
40. 2-terminal fragment complexes that are promoted by the age-dependent decrease in proteasome activity. J. Cell Biol. 163, 109-118.